Johannes E. De Vries

Johannes E. De Vries's AcademicInfluence.com Rankings

Biology

#8016

World Rank

#11025

Historical Rank

Immunology

#444

World Rank

#461

Historical Rank

biology Degrees

Download Badge

Biology

Johannes E. De Vries's Degrees

PhD Immunology University of Amsterdam
Masters Biology University of Amsterdam
Bachelors Biology University of Amsterdam

Similar Degrees You Can Earn

Why Is Johannes E. De Vries Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Johannes E. De Vries's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes (1991) (3960)
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression (1991) (2036)
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. (1993) (1117)
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. (1994) (918)
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells (1996) (861)
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. (1993) (707)
IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. (1988) (706)
Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. (1993) (661)
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. (1990) (544)
Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. (1988) (496)
Biological properties of interleukin 10. (1992) (494)
Identification of Functional Human Splenic Memory B Cells by Expression of CD148 and CD27 (1998) (484)
Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. (1986) (481)
Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. (1984) (436)
Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. (1990) (424)
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells (1994) (424)
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. (1992) (415)
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. (1998) (387)
Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production (1990) (345)
Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. (1997) (335)
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones (1991) (330)
Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level (1996) (317)
Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. (1988) (313)
IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. (1988) (310)
Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. (1991) (274)
IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. (1993) (258)
Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. (1985) (243)
Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. (1991) (237)
Recombinant interleukin 4 promotes the growth of human T cells. (1987) (237)
An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13- induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors (1993) (228)
The role of IL-13 and its receptor in allergy and inflammatory responses. (1998) (227)
T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. (1992) (224)
IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. (1992) (220)
IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. (1993) (209)
Transforming growth factor-beta directs IgA switching in human B cells. (1992) (202)
B cell growth-promoting activity of recombinant human interleukin 4. (1987) (195)
Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes (1997) (190)
Antigen‐specific cytotoxic T cell and antigen‐specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3 (1985) (181)
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. (2004) (178)
Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. (2000) (178)
Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. (1997) (175)
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. (1988) (175)
Immunosuppressive and anti-inflammatory properties of interleukin 10. (1995) (174)
Coordinate regulation of immune and inflammatory responses by T cell‐derived lymphokines (1988) (172)
The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation (1993) (171)
HLA‐DC antigens can serve as recognition elements for human cytotoxic T lymphocytes (1984) (169)
Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. (1983) (162)
Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes (1987) (158)
Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. (1995) (152)
Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA‐1, Mo‐1 and p!50,95 (1985) (152)
Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. (1999) (148)
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. (1984) (146)
The role of monocytes in human lymphocyte activation by mitogens. (1979) (142)
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. (1988) (139)
IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. (2002) (134)
Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. (1992) (134)
Isolation of functionally different human monocytes by counterflow centrifugation elutriation. (1982) (132)
Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon‐γ (1990) (131)
Cytotoxity of non‐T versus T‐lymphocytes from melanoma patients and healthy donors on short‐ and long‐term cultured melanoma cells (1974) (123)
IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. (1994) (122)
Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity. (1982) (118)
IL-4 decreases Fc gamma R membrane expression and Fc gamma R-mediated cytotoxic activity of human monocytes. (1990) (118)
Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. (1997) (115)
Hepatic resections for colorectal metastases in the Netherlands a multiinstitutional 10‐year study (1992) (114)
Diversity and organization of human T cell receptor delta variable gene segments (1989) (110)
Interleukin‐13 is produced by activated human CD45RA+ and CD45R0+ T cells: modulation by interleukin‐4 and interleukin‐12 (1996) (106)
The role of T cell differentiation markers in antigen-specific and lectin-dependent cellular cytotoxicity mediated by T8+ and T4+ human cytotoxic T cell clones directed at class I and class II MHC antigens. (1982) (106)
Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). (1999) (106)
SLAM and its role in T cell activation and Th cell responses (1997) (103)
Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. (1990) (103)
Isolation and characterization of an expressible cDNA encoding human IL-3. Induction of IL-3 mRNA in human T cell clones. (1988) (101)
The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells. (1997) (98)
Characterization of melanoma‐associated surface antigens involved in the adhesion and motility of human melanoma cells (1986) (97)
Cytotoxic lymphocytes in melanoma patients (1972) (96)
Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. (1997) (92)
Genomic organization of the human T-cell antigen-receptor alpha/delta locus. (1988) (91)
Membrane glycoprotein p150,95 of human cytotoxic T cell clone is involved in conjugate formation with target cells. (1987) (90)
Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate‐binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms (2007) (90)
Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. (1991) (90)
Human T4+ and T8+ cytotoxic T lymphocyte clones directed at products of different class II major histocompatibility complex loci. (1983) (90)
Receptors and cytokines involved in allergic TH2 cell responses. (1999) (88)
Lymphoid and myeloid differentiation of fetal liver CD34+lineage- cells in human thymic organ culture (1994) (86)
Modulation of IL‐4‐induced human IgE production in vitro by IFN‐γ and IL‐5: The role of soluble CD23 (s‐CD23) (1989) (82)
Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. (1989) (79)
Natural killer cell clones can efficiently process and present protein antigens. (1991) (79)
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. (1998) (78)
Regulation of the human IgE response by IL4 and IL13. (1993) (77)
Immunoregulatory properties of IL-13: its potential role in atopic disease. (1995) (76)
IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. (1994) (74)
Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique. (1981) (73)
Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes. (1986) (73)
Systematic identification of regulatory proteins critical for T-cell activation (2003) (72)
Interleukin 10 regulates cell surface and soluble LIR‐2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro (2004) (72)
The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands (2007) (70)
Antigen recognition by MHC-incompatible cells of a human mismatched chimera (1988) (69)
Interleukin 13 elicits a subset of the activities of its close relative interleukin 4 (1994) (67)
Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. (1992) (67)
Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. (1997) (67)
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells (2005) (66)
A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells (1984) (62)
The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. (1996) (62)
Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. (1989) (61)
Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156. (1990) (61)
Total parenteral nutrition inhibits intestinal adaptive hyperplasia in young rats: reversal by feeding. (1984) (61)
Complications of splenic artery aneurysm other than intraperitoneal rupture. (1982) (60)
Antibodies and antigen expression in human melanoma detected by the immune adherence test (1975) (60)
In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells. (1995) (58)
IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions. (1989) (56)
Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood. (1991) (55)
The influence of different isolation procedures and the use of target cells from melanoma cell lines and short‐term cultures on the non‐specific cytotoxic effects of lymphocytes from healthy donors (1975) (54)
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. (1991) (53)
Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13. (1995) (52)
Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera (1988) (52)
Effects of interleukin 4 on monocyte functions: comparison to interleukin 13. (1993) (52)
Induction of non-responsiveness in human allergen-specific type 2 T helper cells. (1994) (47)
Development of human connective tissue mast cells from purified blood monocytes. (1984) (46)
Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein. (1996) (46)
Separation of human lymphocytes and monocytes by velocity sedimentation at unit gravity. (1979) (45)
Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes. (1990) (45)
CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation. (1998) (45)
IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. (1995) (44)
Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. (1988) (44)
Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones. (1990) (43)
IFN-alpha and IFN-gamma have different regulatory effects on IL-4-induced membrane expression of Fc epsilon RIIb and release of soluble Fc epsilon RIIb by human monocytes. (1990) (42)
IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor. (1988) (41)
Membranes of activated CD4+ T cells expressing T cell receptor (TcR) αβ or TcR γδ induce IgE synthesis by human B cells in the presence of interleukin‐4 (1992) (41)
Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148. (1998) (41)
Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells. (1992) (39)
A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activity. (1981) (38)
Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells. (1993) (38)
Human T-and B-cell functions in SCID-hu mice. (1996) (37)
Tumour‐associated lymphocyte cytotoxicity superimposed on “Spontaneous” cytotoxicity in melanoma patients (1976) (36)
Successful sentinel node identification in colon carcinoma using Patent Blue V. (2004) (36)
CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells. (1994) (35)
The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens. (1985) (33)
Characterization of a novel CD2+ human thymic B cell subset. (1993) (32)
Inhibition of Vascular Endothelial Growth Factor Cotranslational Translocation by the Cyclopeptolide CAM741 (2007) (32)
IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. (1992) (31)
Haemorrhage from the pancreatic duct: A rare form of upper gastrointestinal bleeding (1984) (31)
Human Ig production and isotype switching in severe combined immunodeficient-human mice. (1993) (30)
The Translocation Inhibitor CAM741 Interferes with Vascular Cell Adhesion Molecule 1 Signal Peptide Insertion at the Translocon* (2006) (30)
Complexity of T cell receptor recognition sites for defined alloantigens. (1987) (29)
T cell clones which share T cell receptor epitopes differ in phenotype, function and specificity (1986) (28)
Molecular and biological characteristics of interleukin-13. (1996) (28)
The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones. (1987) (27)
The role of T/B cell interactions and cytokines in the regulation of human IgE synthesis. (1993) (26)
IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. (1995) (26)
Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester. (1983) (26)
Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. (1992) (26)
Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies. (1987) (26)
Antagonizing the differentiation and functions of human T helper type 2 cells. (1995) (25)
Immunoregulatory functions of paf-acether. VIII. Inhibition of IL-4-induced human IgE synthesis in vitro. (1992) (23)
The replacement of monocytes and interleukin-1 by phorbol ester in lectin-induced proliferation of human thymocytes and T cells. (1982) (22)
Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. (1995) (22)
A family of T-cell receptor molecules expressed on T-cell clones with different specificities for allomajor histocompatibility antigens. (1986) (21)
Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes. (1993) (21)
Human Caco-2 cells transfected with c-Ha-Ras as a model for endocrine differentiation in the large intestine. (1993) (20)
The SCID-hu Skin mouse as a model to investigate selective chemokine mediated homing of human T-lymphocytes to the skin in vivo. (2003) (20)
Introduction of T cell receptor (TCR)-alpha cDNA has differential effects on TCR-gamma delta/CD3 expression by PEER and Lyon-1 cells. (1989) (20)
T-cell growth factor-mediated proliferation of lymphocytes from a T-chronic lymphocytic leukaemia patient lacking mitogen and alloantigen responsiveness. (1981) (20)
CD4 is involved in a post-binding event in the cytolytic reaction mediated by human CD4+ cytotoxic T lymphocyte clones. (1988) (18)
Comparison of lymphokine secretion and responsiveness of human T cell clones isolated in IL-4 and in IL-2. (1991) (18)
Immunoregulatory functions of paf-acether. VI. Inhibition of T cell activation via CD3 and potentiation of T cell activation via CD2. (1990) (17)
Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones. (1998) (17)
Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+ T cells or their membranes. (1993) (17)
Interleukin-4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells. (1990) (16)
The role of target cells, monocytes, and Fc receptor-bearing lymphocytes in human spontaneous cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity. (1980) (16)
Expression of soluble human signaling lymphocytic activation molecule in vivo. (1999) (16)
The response of selected human B cell lines to B cell growth and differentiation factors (1987) (16)
Do human TH1 and TH2 CD4+ clones exist? (1991) (16)
Long-term effects of fatty acids on cell viability and gene expression of neonatal cardiac myocytes. (1997) (16)
Enhanced expression of human T‐cell leukemia/lymphoma virus in neoplastic T cells induced to proliferate by phorbol ester and interleukin‐2 (1983) (15)
Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist. (1995) (15)
Theory and practice of centrifugal elutriation (CE). Factors influencing the separation of human blood cells. (1983) (14)
Modulation of the human IgE response. (1996) (14)
Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays. (2005) (14)
Two novel haemoglobin variants that affect haemoglobin A1c measurement by ion-exchange chromatography (2015) (14)
[Lymphoid hyperplasia of the colon]. (1979) (13)
Regulation of human IgE synthesis: the role of CD4+ and CD8+ T-cells and the inhibitory effects of interferon-alpha. (1991) (13)
Antigen-specific, but not natural killer, activity of T cell receptor-gamma delta cytotoxic T lymphocyte clones involves secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and influx of Ca2+ ions. (1989) (12)
Spontaneous expression of a low affinity Fc receptor for IgA (Fc alpha R) on human B cell lines. (1989) (12)
p21ras in carcinogenesis. (1996) (12)
Distribution and functional analysis of a 120- to 130-kDa T-cell surface antigen. (1987) (12)
Clinical experience with the medical anti-shock trousers (MAST) treatment of hemorrhage, especially from compound pelvic fracture. (1980) (12)
Rapid isolation of mononuclear cells from buffy coats prepared by a new blood cell separator. (1982) (11)
Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering. (1999) (11)
Effect of luminal contents on postresectional longitudinal and mucosal growth in the ileum of suckling rats. (1985) (11)
Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones. (1989) (10)
Isolation of human thymocytes differing in maturation state and function by centrifugal elutriation. (1982) (10)
Membranes of activated CD4+ T cells expressing T cell receptor (TcR) alpha beta or TcR gamma delta induce IgE synthesis by human B cells in the presence of interleukin-4. (1992) (10)
PCR on cell lysates obtained from whole blood circumvents DNA isolation. (2001) (9)
Human T cell lines differing in phenotype and specificity are reactive with the same anti-idiotypic antibody. (1986) (9)
Prognostic scoring systems in differentiated thyroid carcinoma: which is the best? (1991) (9)
Phorbol-ester-mediated induction and augmentation of mitogenesis and interleukin-2 production in human T-cell lymphoproliferative disease. (1982) (9)
A SCID patient reconstituted with HLA-incompatible fetal stem cells as a model for studying transplantation tolerance. (1991) (8)
Excellent prognosis of node negative patients after sentinel node procedure in colon carcinoma: a 5-year follow-up study. (2014) (8)
The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients (1980) (7)
Sensitive and quantitative determination of monocyte adherence. (1986) (7)
The role of Ca2+ and Mg2+ in the cytotoxic T lymphocyte reaction and in the secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester-serine esterase by human T cell clones. (1989) (7)
Regulation of IgE synthesis by T cells and cytokines. (1993) (7)
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture. (1984) (6)
The molecular cloning of interleukins 4, 5 and 6: multifunctional hemopoietic growth factors. (1988) (6)
Growth and metabolic alterations after submandibular sialadenectomy in male mice. (1983) (6)
The cell-mediated lympholysis-inducing capacity of highly purified human monocytes and T lymphocytes in primary and secondary mixed leukocyte cultures. (1981) (6)
Disorder in the Serotonergic System due to Tryptophan Hydroxylation Impairment: A Cause of Hypothalamic Syndrome? (2010) (6)
A practical method for decreasing the serum cholesterol level in man. (1969) (5)
Immunological studies in melanoma patients treated with BCG. (1973) (5)
Treatment of pancreatic injuries. (1984) (5)
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--II. Inhibition of lymphoproliferative responses. (1984) (4)
Metabolic blocker-induced cell damage in rat cardiac tissue. Comparison of three models currently used: the isolated perfused heart, heart cell cultures and isolated myocytes. (1984) (4)
Up-regulation of receptors for IgA on activated human B lymphocytes. (1988) (4)
Novel fundamental approaches to intervening in IgE-mediated allergic diseases. (1994) (4)
Dietary sugar and serum-cholesterol. (1968) (4)
Separation of viable from nonviable tumor cells by flotation on a Ficoll-Triosil mixture. (1973) (4)
Intestinal Resection in the Neonatal Rat: Stimulus for Precocious Intestinal Maturation (1985) (4)
Induction of IL‐2 production, IL‐2 receptor expression and proliferation of T3− T‐PLL cells by phorbol ester (1984) (4)
[Mazabraud syndrome--benign intramuscular myxoma with fibrous skeletal dysplasia]. (2011) (3)
Chromosomal localization of transfected genes by a combination of hot banding and fluorescence in situ hybridization. (1992) (3)
Pillars Article: The X-Linked Lymphoproliferative Disease Gene Product SAP Regulates Signals Induced through the Co-Receptor SLAM. Nature. 1998. 395: 462-469. (2017) (3)
Contact-mediated signals and cytokines involved in B-cell activation and isotype switching in pre-B and mature B cells. (1994) (3)
Nonsurgical treatment of pelvic hemorrhage in obstetric and gynecologic patients. (1987) (3)
[Interval appendectomy as indicated rather than as routine therapy: fewer operations and shorter hospital stays]. (2007) (2)
Tumorigenic behaviour of c-Ha-ras oncogene transfected CaCo 2 cells is associated with increased proteolytic potency. (1996) (2)
MDR-1 AND CYP P450 GENE POLYMORPHISMS AND 12-HR AUC PHARMACOKINETICS OF TACROLIMUS. (2004) (2)
Peptide induced anergy of human allergen-specific T cells. (1996) (1)
Effects of submandibular sialadenectomy on N-methyl-N'-nitro-N-nitrosoguanidine-induced duodenal carcinogenesis in mice. (1985) (1)
Problems in the use of in vitro assays for monitoring cell-mediated immunity in cancer patients. (1976) (1)
Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft. (1990) (1)
Atopic allergy and other hypersensitivities. (1994) (0)
[10 years of infraclavicular biopsy in breast cancer]. (1983) (0)
Inhibition of IL-4- and IL-13-induced IgE synthesis by an IL-4 mutant protein. (1994) (0)
[Diagnostic image (158). A woman with a painful cord below and a dimple in the breast. Mondor's disease]. (2003) (0)
[Painful breasts]. (1998) (0)
Pancreatic pleural effusion in a patient with chronic pancreatitis. (1983) (0)
Somatostatin in acute pancreatitis. (1987) (0)
[Laparoscopic inguinal hernia surgery: (for the time being) marking time]. (1996) (0)
Molecular biology of T cell-derived lymphokines: structure and biology of interleukin 4. (1988) (0)
[Treatment of hypovolemic shock with external compression of the lower body using a pressure suit]. (1980) (0)
False positive peritoneal lavage due to retroperitoneal haematoma. (1980) (0)
c-Ha-ras oncogene transfection does not affect NK cell sensitivity of human colorectal carcinoma cell lines. (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Johannes E. De Vries?

Johannes E. De Vries is affiliated with the following schools:

Johannes E. De Vries's Academic­Influence.com Rankings